News
Corcept Therapeutics Incorporated (NASDAQ:CORT) said on Thursday that it presented results from its Phase 2 DAZALS study of ...
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of ...
Prescribed use of anti-anxiety drugs, hypnotics and sedatives, or antidepressants was tied to a higher future risk of ...
13hon MSNOpinion
Nothing is clicking for a Rangers offense that is so bad, it has made its great pitching staff nearly irrelevant. | Opinion ...
The donation will establish the Lois Pope Neuroscience Research Fund and will add Lorraine's name to the Lois Pope Laboratory ...
Corcept Therapeutics has tried to cast its recent phase 2 amyotrophic lateral sclerosis (ALS) failure in a more flattering ...
Brainstorm tapped Minaris to manufacture NurOwn for its upcoming Phase 3b clinical trial testing the treatment for ALS.
UC Irvine researchers conducted a study to better understand the molecular basis of amyotrophic lateral sclerosis (ALS), a ...
6h
Worcester Telegram on MSN'I miss her deeply': Clark University professor and 'Hometown Hero' Amy Richter diesRichter died on Monday, June 2, after a brief illness. A celebration of her life and legacy will be celebrated at a future date.
As part of ALS Awareness Month, the Miami Marlins recognized Lou Gehrig’s legacy and the fight against ALS during a special ...
Corcept Therapeutics' dazucorilant failed the primary ALS trial goal but showed improved survival outcomes and a safe profile ...
It’s been nearly a year since Charlottesville lost one of its most respected pediatricians. At 65, he was diagnosed with a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results